Literature DB >> 3110251

A four generation study of familial dysalbuminemic hyperthyroxinemia: diagnosis in the presence of an acquired excess of thyroxine-binding globulin.

P P Yeo, Y Yabu, J R Etzkorn, R Rajatanavin, L E Braverman, S H Ingbar.   

Abstract

We have studied the largest kindred with familial dysalbuminemic hyperthyroxinemia (FDH) thus far reported, comprising thirty-three blood relations in four generations and three of their spouses. Our objective was to complement previous evidence concerning the precise mode of inheritance of FDH and to detect any other features of the disorder that had not yet been noted. Among the thirty three, there were thirteen patients with FDH, eight males and five females, in all of whom the abnormality appeared to be fully expressed. Within the kindred, no affected female has borne a female child, but transmission from female to male, male to male, and male to female has been observed. Among the offspring of individuals with FDH, the overall observed frequency of FDH in three filial generations was 12/22, or 54.5 per cent, yielding a computed penetrance ratio of 1.09. Four of the patients with FDH had been investigated for hyperthyroidism, and two of them had mistakenly been treated. Of particular interest were two women with FDH who were receiving oral contraceptives and whose serum thyroxine-binding globulin (TBG) concentrations were increased. The results of their thyroid function tests differed from those of patients with FDH whose TBG concentrations were normal and mainly suggested the presence of only a high TBG state. The diagnosis of FDH in these two patients was obscured, and probably would not have been made were it not for the present investigation, which led to the electrophoretic demonstration of increased binding of T4 by serum albumin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110251     DOI: 10.1007/BF03347147

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Specific methods to identify plasma binding abnormalities in euthyroid hyperthyroxinemia.

Authors:  J R Stockigt; S A Dyer; V S Mohr; E L White; J W Barlow
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

2.  Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin.

Authors:  J R Stockigt; D J Topliss; J W Barlow; E L White; D M Hurley; P Taft
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

4.  Hyperthyroxinemia associated with high thyroxine binding to albumin in euthyroid subjects.

Authors:  P De Nayer; P Malvaux
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

5.  Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma.

Authors:  R Rajatanavin; C Liberman; G D Lawrence; C M D'Arcangues; R A Young; C H Emerson
Journal:  J Clin Endocrinol Metab       Date:  1985-07       Impact factor: 5.958

6.  Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease.

Authors:  R A Young; S S Stoffer; L E Braverman
Journal:  Am J Med       Date:  1987-02       Impact factor: 4.965

7.  Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis.

Authors:  M Ruiz; R Rajatanavin; R A Young; C Taylor; R Brown; L E Braverman; S H Ingbar
Journal:  N Engl J Med       Date:  1982-03-18       Impact factor: 91.245

8.  A new and distinctive albumin variant with increased affinities for both triiodothyronines and causing hyperthyroxinaemia.

Authors:  M R Lalloz; P G Byfield; R L Himsworth
Journal:  Clin Endocrinol (Oxf)       Date:  1985-04       Impact factor: 3.478

9.  Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin.

Authors:  J W Barlow; J M Csicsmann; E L White; J W Funder; J R Stockigt
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

10.  Hyperthyroxinaemia: abnormal binding of T4 by an inherited albumin variant.

Authors:  M R Lalloz; P G Byfield; R L Himsworth
Journal:  Clin Endocrinol (Oxf)       Date:  1983-01       Impact factor: 3.478

View more
  1 in total

1.  A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia.

Authors:  A C Moses; H N Rosen; D E Moller; S Tsuzaki; J E Haddow; J Lawlor; J J Liepnieks; W C Nichols; M D Benson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.